Angiotensin Converting Enzyme Inhibitors - Renal Disorders

Relevant Publications

Comment on: Influence of cardiometabolic medications on abdominal aortic aneurysm growth in the UK Aneurysm Growth Study: metformin and angiotensin-converting enzyme inhibitors associated with slower aneurysm growth.

Issue Release: 2024

Reassessing heart failure therapy in Thailand: Patient insights and treatment outcomes from the Thai heart failure registry.

Issue Release: 2024

Classical and nonclassical effects of angiotensin-converting enzyme: How increased ACE enhances myeloid immune function.

Issue Release: 2024

Diagnosis and management of resistant hypertension.

Issue Release: 2024

Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics.

Issue Release: 2024

Burden of Disease Associated with Refractory and Unexplained Chronic Cough in Canada: Results from a National Survey.

Issue Release: 2024

Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin II receptor blockers: a retrospective cohort study using LIFE Study data.

Issue Release: 2024

Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-CoV-2 PLpro.

Issue Release: 2024

Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019.

Issue Release: 2024

Concordance With Screening and Treatment Guidelines for Chronic Kidney Disease in Type 2 Diabetes.

Issue Release: 2024

Renin-angiotensin system inhibitors positively impact on multiple aging regulatory pathways: Could they be used to protect against human aging?

Issue Release: 2024

Exploration of Gene Therapy for Alport Syndrome.

Issue Release: 2024

Biosensor-based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose.

Issue Release: 2024

Engineering a NanoBiT biosensor for detecting angiotensin-converting enzyme-2 (hACE2) interaction with SARS-CoV-2 spike protein and screening the inhibitors to block hACE2 and spike interaction.

Issue Release: 2024

Mathematical modeling for prediction of physicochemical characteristics of cardiovascular drugs via modified reverse degree topological indices.

Issue Release: 2024

A retrospective analysis of e-prescriptions for non-communicable diseases on a telehealth platform in Malaysia.

Issue Release: 2024

Predictors of overall mortality after endovascular abdominal aortic repair - A single centre study.

Issue Release: 2024

Anti-SARS-CoV-2 Viral Activity of Sweet Potato Trypsin Inhibitor via Downregulation of TMPRSS2 Activity and ACE2 Expression In Vitro and In Vivo.

Issue Release: 2024

Cardiorenal effects of Angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers in people underrepresented in trials: analysis of routinely collected data with emulation of a reference trial (ONTARGET).

Issue Release: 2024

The potential role of brain renin-angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?

Issue Release: 2024

What are Autoimmune Diseases?

What is a Kidney Biopsy?

What is Kidney Transplantation?

What are the Symptoms?

How do NSAIDs affect the kidneys?

How Do These Medications Work?

Can dialysis patients take the same medications as those with normal renal function?

What is the Procedure Like?

Can Alcohol-Induced Kidney Damage Be Reversed?

What is the Prognosis for Patients with Renal Disorders?

Angiotensin Converting Enzyme Inhibitors - Renal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics